Publicaciones en colaboración con investigadores/as de Hospital Arnau de Vilanova (53)

2026

  1. Clinical Factors Associated With Current Relevance in Allergic Contact Dermatitis: Development of Predictive Models Based on Data From the Spanish Contact Dermatitis Register (REIDAC)

    Contact Dermatitis, Vol. 94, Núm. 6, pp. 614-623

  2. Cost-effectiveness of personalized medical treatment in acromegaly: A post hoc analysis of the ACROFAST study

    Journal of the Endocrine Society, Vol. 10, Núm. 4

  3. Epidemiological, Clinical and Allergic Profile of Patients With Dyshidrotic Eczema (Acute and Recurrent Vesicular Dermatitis): Evaluation of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy (REIDAC)

    Contact Dermatitis

  4. Influence of the level of education on cognitive function in Parkinson’s disease

    Journal of Neural Transmission, Vol. 133, Núm. 4, pp. 663-681

  5. Is there a window of opportunity in the treatment of giant cell arteritis with tocilizumab? Multicenter study of 471 patients

    Seminars in Arthritis and Rheumatism, Vol. 78

  6. Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study

    American Journal of Hematology

2025

  1. Autologous or Allogeneic Hematopoietic Stem Cell Transplantation as Front-Line Treatment for Adult Secondary Acute Myeloid Leukemia Patients: The PETHEMA Registry Experience

    Transplantation and Cellular Therapy, Vol. 31, Núm. 5, pp. 299.e1-299.e14

  2. Correction to: Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline (Journal of Neurology, (2025), 272, 3, (246), 10.1007/s00415-024-12808-0)

    Journal of Neurology

  3. Dysphagia in Parkinson´s disease. A 5-year follow-up study

    Neurological Sciences, Vol. 46, Núm. 6, pp. 2637-2653

  4. Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real-world data study

    European Journal of Neurology, Vol. 32, Núm. 1

  5. Efficient Management of Severe Asthma in the Clinic

    Open Respiratory Archives, Vol. 7, Núm. 3

  6. Evaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (HERMeS): a multicentre, randomised controlled trial

    The Lancet Digital Health, Vol. 7, Núm. 5

  7. Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline

    Journal of Neurology, Vol. 272, Núm. 3

  8. Hypochloremia in chronic and acute heart failure scenarios: Prevalence and risk factors

    European Journal of Internal Medicine, Vol. 139

  9. Identification of phenotypes and predictors for dyspnea, echocardiographic probability of pulmonary hypertension, and confirmed CTEPH in patients with acute pulmonary embolism: Analysis of two large patient cohorts

    Thrombosis Research

  10. Intervención telemática sobre la fragilidad en pacientes tratados con TAVI: diseño del ensayo clínico TELE-FRAIL TAVI

    REC: Interventional Cardiology, Vol. 7, Núm. 4, pp. 223-228

  11. Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry

    Leukemia, Vol. 39, Núm. 11, pp. 2686-2696

  12. Parkinson’s disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial

    npj Parkinson's Disease, Vol. 11, Núm. 1

  13. Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023

    Contact Dermatitis, Vol. 92, Núm. 2, pp. 120-130

  14. Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019–2022 prospective study with cluster and network analysis

    Journal of the European Academy of Dermatology and Venereology, Vol. 39, Núm. 1, pp. 126-135